EPCAM and neoplasm: The free and virally encoded EpCAM BiTE also induced significant T‐cell activation of tumour‐associated lymphocytes (assessed by CD25 expression) in all patients' samples, even within the likely immune‐tolerising environment of the malignant exudate fluid (Fig 9B).